Medicine Bristol Myers Squibb Reveals Promising Results from Trial of Zeposia for Multiple Sclerosis March 3, 2024 - By admin Phase III DAYBREAK study found consistent safety with Zeposia in patients with relapsing forms of multiple sclerosis.